STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor ...

Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the ...

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - June 25, 2025Idorsia Ltd. (SIX: IDIA) today announced the positive outcome of two bondholder meetings held at 17:30 CEST and 19:00 ...

AGM/EGM/DividendDermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share 26.06.2025 / 17:43 CET/CESTThe issuer is solely responsible for the content of this ...

Sobi® (STO: SOBI), today announced a capped royalty purchase agreement with Apellis Pharmaceuticals, Inc. under which Sobi will reduce ...

European stock markets opened in subdued fashion on Tuesday morning after dropping to their lowest in six weeks the previous session, as ongoing uncertainty surrounding the conflict in the Middle East ...